FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

5008611000001106: Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
23497101000001119 Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38525301000001113 Meglumine amidotrizoate 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml Is pack of Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free false Inferred relationship Existential restriction modifier
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml Has active ingredient Meglumine amidotrizoate false Inferred relationship Existential restriction modifier
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml Has active ingredient Sodium amidotrizoate false Inferred relationship Existential restriction modifier
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml Has manufactured dose form Conventional release oral solution false Inferred relationship Existential restriction modifier
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml Has VMP Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free true Inferred relationship Existential restriction modifier
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml Has specific active ingredient Meglumine amidotrizoate true Inferred relationship Existential restriction modifier
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml Has specific active ingredient Sodium amidotrizoate true Inferred relationship Existential restriction modifier
Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Gastrografin oral solution (Schering Health Care Ltd) 100 ml Is a True Meglumine 3.3g/5ml / Sodium amidotrizoate 500mg/5ml oral solution sugar free 100 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start